Esperion Therapeutics | SCHULD

Aktienkurs
3.46
Täglich Wechseln
0.07 2.06%
Monatlich
-2.54%
Jährlich
84.04%
Q1 Prognose
2.70




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Cipla INR 4.38B 231.9M 2025-03
CSL USD 11.96B 219M 2024-12
Cytokinetics USD 858.06M 199.93M 2025-06
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Geron USD 121.84M 3.12M 2025-06
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 741M 4M 2025-06
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12


Esperion Therapeutics SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.